Control of myeloid lineage fidelity and response to stimuli by ISWI-enforced nucleosome phasing
Immunity · 2025
DOI: 10.1016/j.immuni.2025.09.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, 2025. Verfasst von Sara Polletti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Oncology, European Institute of Oncology, IEO IRCCS, Milan, Italy. Electronic address: sara.polletti@ieo.it. Hauptthemen laut MEDLINE: Nucleosomes, Macrophages, Transcription Factors, Myeloid Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: AIRC Foundation for Cancer Research, GAČR, NextGenerationEU.
Abstract (Originalsprache)
The interplay between chromatin remodelers and pioneer transcription factors (TFs) regulates cis-regulatory element accessibility to maintain cell identity and transcriptional fidelity. We investigated the impact of imitation of switch (ISWI) chromatin remodelers, key regulators of nucleosome spacing, on macrophage differentiation and activation, focusing on SMARCA5, the sole ISWI ATPase in myeloid cells. Conditional Smarca5 deletion in bone marrow-derived macrophages disrupted nucleosome phasing near sites bound by PU.1, a pioneer TF essential for myeloid identity, without altering PU.1 occupancy. However, SMARCA5 loss increased accessibility at motifs bound by C/EBPβ, a weak pioneer TF, enabling binding to regulatory regions active in non-hematopoietic lineages and causing lineage-inappropriate transcription. These changes also increased accessibility at sites bound by stimulus-induced TFs, leading to macrophage hyperactivation and mis-expression of stimulus-inappropriate genes. Thus, SMARCA5-dependent nucleosome phasing restrains C/EBPβ and stimulus-induced TF binding, ensuring transcriptional fidelity during macrophage lineage specification and activation, with likely similar roles in other immune cell types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Oncology, European Institute of Oncology, IEO IRCCS, Milan, Italy. Electronic address: sara.polletti@ieo.it.
- Department of Experimental Oncology, European Institute of Oncology, IEO IRCCS, Milan, Italy.
- BIOCEV, First Faculty of Medicine, Charles University, Prague, Czechia.
- Department of Experimental Oncology, European Institute of Oncology, IEO IRCCS, Milan, Italy. Electronic address: francesco.gualdrini@ieo.it.
- Department of Experimental Oncology, European Institute of Oncology, IEO IRCCS, Milan, Italy. Electronic address: gioacchino.natoli@ieo.it.
Förderung
- AIRC Foundation for Cancer Research
- GAČR
- NextGenerationEU
- EU Framework Programme for Research and Innovation Marie Skłodowska-Curie Actions
- Ministero della Salute
- European Research Council
- Istituto di Ricovero e Cura a Carattere Scientifico
- Associazione Italiana per la Ricerca sul Cancro
Zitieren
APA
Polletti, S., Melià-Alomà, J., Pileri, F., Di Lena, C. A., Piccolo, V., Cuomo, A., Stopka, T., Gualdrini, F., & Natoli, G. (2025). Control of myeloid lineage fidelity and response to stimuli by ISWI-enforced nucleosome phasing. Immunity. https://doi.org/10.1016/j.immuni.2025.09.002
Vancouver
Polletti S, Melià-Alomà J, Pileri F, Di Lena CA, Piccolo V, Cuomo A, et al. Control of myeloid lineage fidelity and response to stimuli by ISWI-enforced nucleosome phasing. Immunity. 2025. doi:10.1016/j.immuni.2025.09.002
BibTeX
@article{Polletti2025,
author = {Polletti, Sara and Melià-Alomà, Júlia and Pileri, Francesco and Di Lena, Chiara Anna and Piccolo, Viviana and Cuomo, Alessandro and Stopka, Tomas and Gualdrini, Francesco and Natoli, Gioacchino},
title = {Control of myeloid lineage fidelity and response to stimuli by ISWI-enforced nucleosome phasing},
journal = {Immunity},
year = {2025},
doi = {10.1016/j.immuni.2025.09.002}
}
EUVIMED